• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].

作者信息

Motohiro T, Oda K, Aramaki M, Tanaka K, Kawakami A, Shimada Y, Koga T, Tomita S, Sakata Y, Fujimoto T

机构信息

Department of Pediatrics, School of Medicine, Kurume University.

出版信息

Jpn J Antibiot. 1988 Mar;41(3):276-305.

PMID:3404647
Abstract

Following a one shot injection with ceftriaxone (CTRX) 10 mg/kg or 20 mg/kg into 23 neonates (1 to 24 days old) including premature infants, plasma levels of CTRX were measured up to 12 hours post-dose in some cases and up to 72 hours post-dose in others and also urinary levels and urinary recovery rates were determined up to 12 hours post-dose. Furthermore, clinical, bacteriological and infection-prophylactic effects of CTRX were evaluated by the intravenous administration with the mean dose of CTRX of 47.7 mg/kg once daily or half the dose twice daily for 9 days on the average into 46 infants (0 to 6 months old) including neonates and premature infants; i.e., 21 cases with actual or suspected bacterial infections for the evaluation of clinical and bacteriological effects and 25 without bacterial infection for the evaluation of prophylactic effects against bacterial infection. The safety of CTRX was evaluated in 53 cases including 7 which were omitted from the efficacy evaluation due to adverse reactions and also in some cases from clinical laboratory parameters. The following is a summary of the results obtained: 1. Following the administration with CTRX 10 mg/kg into each of the neonates 6, 12, 13 and 21 days old (the 21 old one was premature), plasma levels of CTRX in these subjects reached their peaks at 5 minutes post-dose at levels of 59.38, 53.13, 37.50 and 50.00 micrograms/ml, respectively. The peak levels were similar to each other with an exception of the rather low level in the 13 day-old neonate. The plasma half-life times of CTRX in these subjects were 9.762, 7.775, 7.330 and 8.149 hours, respectively: The younger the infant the longer the half-life tended to be except the premature cases. Similarly, the younger the infant the larger the AUC was except for the premature case with the AUC values of 511.169, 324.714, 236.346 and 326.825 micrograms.hr/ml, respectively. The Vds were 0.709, 1.004, 1.316 and 0.696 liters, respectively, and the value for 13 day-old neonate was the largest. Urinary levels of CTRX reached between 42.00 and 298.30 micrograms/ml at some time within 12 hours post-dose in any cases. Urinary recovery rates in 12 hours post-dose were 79.98, 52.00, 56.82 and 60.14%, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

相似文献

1
[Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].
Jpn J Antibiot. 1988 Mar;41(3):276-305.
2
[Pharmacokinetic and clinical evaluation of ceftriaxone in neonates and premature infants].
Jpn J Antibiot. 1988 Mar;41(3):244-61.
3
[Pharmacokinetic and clinical evaluations on ceftriaxone in neonates].新生儿头孢曲松的药代动力学与临床评估
Jpn J Antibiot. 1988 Mar;41(3):262-75.
4
[Pharmacokinetics and clinical evaluation of ceftriaxone in neonates].
Jpn J Antibiot. 1988 Sep;41(9):1237-50.
5
[Pharmacokinetic and clinical evaluations on ceftriaxone in neonates and premature infants].
Jpn J Antibiot. 1988 Mar;41(3):236-43.
6
[Clinical evaluation of ceftriaxone in the treatment of neonatal infections].头孢曲松治疗新生儿感染的临床评估
Jpn J Antibiot. 1988 Feb;41(2):152-64.
7
[Pharmacokinetic and clinical studies of ceftriaxone in neonates].头孢曲松在新生儿中的药代动力学及临床研究
Jpn J Antibiot. 1988 Feb;41(2):144-50.
8
[Ceftriaxone in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on intestinal bacterial flora].
Jpn J Antibiot. 1988 Feb;41(2):117-27.
9
[Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
Jpn J Antibiot. 1986 Aug;39(8):1988-2008.
10
[Evaluation on ceftriaxone administered intravenously in neonates].[新生儿静脉注射头孢曲松的评估]
Jpn J Antibiot. 1988 Mar;41(3):225-35.

引用本文的文献

1
Human cytomegalovirus promoting endothelial cell proliferation by targeting regulator of G-protein signaling 5 hypermethylation and downregulation.人巨细胞病毒通过靶向 G 蛋白信号调节因子 5 的高甲基化和下调促进血管内皮细胞增殖。
Sci Rep. 2020 Feb 10;10(1):2252. doi: 10.1038/s41598-020-58680-6.